LRFN4 and rectum adenocarcinoma: Despite the unavailability of certain data, such as rectum adenocarcinoma (READ) on the cBioPortal platform (36), the prevalence of LRFN4 alterations in digestive system malignancies was evaluated, showing an overall incidence of 3% (Supplementary Figure S1A).